Showing results (31-40 of 81) with videos related to
Sort By:
Pageof 9
Drugs of Today (Barcelona, Spain : 1998)|February 13, 2003
The pathophysiology of benign prostatic hyperplasiaBob Djavan, Mesut Remzi, Beate Erne, et al.Current Opinion in Urology|April 20, 2004
Benign prostatic hyperplasia progression and its impact on treatmentBob Djavan, Matthias Waldert, Clemens Ghawidel, et al.European Urology|May 28, 2003
Artificial neural networks for decision-making in urologic oncologyTheodore Anagnostou, Mesut Remzi, Michael Lykourinas, et al.The Canadian Journal of Urology|August 13, 2013
Vitamin D and benign prostatic hyperplasia -- a reviewGeovanni Espinosa, Ralph Esposito, Amir Kazzazi, et al.European Urology|June 21, 2002
Efficacy of oral doxepin and piroxicam treatment for interstitial cystitisRobert Wammack, Mesut Remzi, Christian Seitz, et al.The Canadian Journal of Urology|April 20, 2010
5A prospective survey of current prostate biopsy practices among oncological urologistsSimon Brewster, Levent Turkeri, Maurizio Brausi, et al.The Canadian Journal of Urology|April 21, 2011
New findings in bladder and prostate cancer: highlights from the 26th annual congress of the European Association of Urology, March 18-22, 2011, Vienna, AustriaAlex Farr, Roman Herout, Markus Margreiter, et al.Current Opinion in Urology|November 20, 2012
Correlation between benign prostatic hyperplasia and inflammationYakup Bostanci, Amir Kazzazi, Shabnam Momtahen, et al.Annals of the New York Academy of Sciences|January 26, 2011
Chemopreventive effects of resveratrol and resveratrol derivativesThomas Szekeres, Philipp Saiko, Monika Fritzer-Szekeres, et al.European Urology|January 1, 2003
PSA progression following radical prostatectomy and radiation therapy: new standards in the new MillenniumBob Djavan, Judd W Moul, Alexandre Zlotta, et al.Pageof 9